The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
Open accessAbstract
Huntington’s disease (HD) is a progressive, multifaceted neurodegenerative disease associated with weight loss and gut problems. Under healthy conditions, tight junction (TJ) proteins maintain the intestinal barrier integrity preventing bacterial translocation from the intestinal lumen to the systemic circulation. Reduction of TJs expression in Parkinson’s disease patients has been linked with increased intestinal permeability—leaky gut syndrome. The intestine contains microbiota, most dominant phyla being Bacteroidetes and Firmicutes ; in pathogenic or disease conditions the balance between these bacteria might be disrupted. The present study investigated whether there is evidence for an increased intestinal permeability and dysbiosis in the R6/2 mouse model of HD. Our data demonstrate that decreased body weight and body length in R6/2 mice is accompanied by a significant decrease in colon length and increased gut permeability compared to wild type littermates, without any significant changes in the protein levels of the tight junction proteins (occludin, zonula occludens). Moreover, we found an altered gut microbiota in R6/2 mice with increased relative abundance of Bacteroidetes and decreased of Firmicutes . Our results indicate an increased intestinal permeability and dysbiosis in R6/2 mice and further studies investigating the clinical relevance of these findings are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the study did not observe an increase in Bacteroidetes and a reduction in Firmicutes, as reported in both R6/1 and R6/2 mice.235,236”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [236]
In the citing paper
“It was found that R6/2 mice exhibited increased intestinal permeability and reduced colon length at 16 weeks of age (early-mid disease stage), as compared to age-matched WT mice.236”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [236]
In the citing paper
“Moreover, a higher relative abundance of Bacteroidetes and a lower relative abundance of Firmicutes were reported in both R6/1 and R6/2 mice, as compared to WT mice.235,236”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [236]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,246
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Quality control and preprocessing of metagenomic datasets
Schmieder, R., & Edwards, R. A. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr026 · Cited by 5,119
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Role of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375
Hematoxylin and Eosin Staining of Tissue and Cell SectionsPreprint
Fischer, A. H., Jacobson, K. A., Rose, J., & Zeller, R. (2008) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot4986 · Cited by 2,240
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
The Integrative Human Microbiome Project
The Integrative HMP (iHMP) Research Network Consortium, Proctor, L. M., Creasy, H. H., Fettweis, J. M., Lloyd-Price, J., Mahurkar, A., Zhou, W., Buck, G. A., Snyder, M. P., Strauss, J. F., et al. (2019) · Nature · doi:10.1038/s41586-019-1238-8 · Cited by 1,381
Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice
Sharon, G., Cruz, N. J., Kang, D.-W., Gandal, M. J., Wang, B., Kim, Y.-M., Zink, E. M., Casey, C. P., Taylor, B. C., Lane, C. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.004 · Cited by 1,182
Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1,2
Ulluwishewa, D., Anderson, R. C., McNabb, W. C., Moughan, P. J., Wells, J. M., & Roy, N. C. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135657 · Cited by 1,177
Human Fecal Flora: The Normal Flora of 20 Japanese-Hawaiians
Moore, W. E. C., & Holdeman, L. V. (1974) · Applied Microbiology · doi:10.1128/am.27.5.961-979.1974 · Cited by 1,144
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.
Fasano, A., Baudry, B., Pumplin, D. W., Wasserman, S. S., Tall, B. D., Ketley, J. M., & Kaper, J. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5242 · Cited by 579
Sturgeon, C., & Fasano, A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1251384 · Cited by 497
Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.
Cénac, N., Coelho, A., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W., Wallace, J., Hollenberg, M., Bunnett, N., Garcia-Villar, R., et al. (2002) · American Journal of Pathology · doi:10.1016/s0002-9440(10)64466-5 · Cited by 386
Asmar, R. E., Panigrahi, P., Bamford, P. D., Berti, I., Not, T., Coppa, G. V., Catassi, C., & Fasano, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.36578 · Cited by 369
Fukui, H. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000447252 · Cited by 358
Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse
Tabrizi, S. J., Workman, J. M., Hart, P. E., Mangiarini, L., Mahal, A., Bates, G. P., Cooper, J. A. D., & Schapira, A. H. V. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200001)47:1 · Cited by 353
Pozuelo, M., Panda, S., Santiago, A., Mendez, S., Accarino, A. M., Santos, J., Guarner, F., Azpiroz, F., & Manichanh, C. (2015) · Scientific Reports · doi:10.1038/srep12693 · Cited by 338
Structural alterations of the intestinal epithelial barrier in Parkinson’s disease
Clairembault, T., Leclair‐Visonneau, L., Coron, E., Bourreille, A., Dily, S. L., Vavasseur, F., Heymann, M., Neunlist, M., & Derkinderen, P. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0196-0 · Cited by 305
Drouin‐Ouellet, J., Sawiak, S. J., Cisbani, G., Lagacé, M., Kuan, W., Saint‐Pierre, M., Dury, R. J., Alata, W., St‐Amour, I., Mason, S. L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24406 · Cited by 288
Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease
Kong, G., Cao, K.-A. L., Judd, L. M., Li, S., Renoir, T., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.001 · Cited by 212
The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies
Perez-Pardo, P., Kliest, T., Dodiya, H. B., Broersen, L. M., Garssen, J., Keshavarzian, A., & Kraneveld, A. D. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.042 · Cited by 203
Leaky gut biomarkers in depression and suicidal behavior
Ohlsson, L., Gustafsson, A., Lavant, E. H., Suneson, K., Brundin, L., Westrin, Å., Ljunggren, L., & Lindqvist, D. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12978 · Cited by 186
Björkqvist, M., Fex, M., Renström, E., Wierup, N., Petersén, Å., Gil‐Mohapel, J., Bacos, K., Popović, N., Li, J., Sundler, F., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi053 · Cited by 143
Self-citationBeighton, P., & Hayden, M. R. (1981) · PubMed · Cited by 142
Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice
Morton, A. J., Glynn, D., Leavens, W., Zheng, Z., Faull, R. L. M., Skepper, J. N., & Wight, J. M. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.015 · Cited by 126
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice
van der Burg, J. M. M., Winqvist, A., Aziz, N. A., Maat–Schieman, M. L. C., Roos, R. A. C., Bates, G. P., Brundin, P., Björkqvist, M., & Wierup, N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.006 · Cited by 111
Self-citationImpairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
Pardo, A. D., Amico, E., Scalabrì, F., Pepe, G., Castaldo, S., Elifani, F., Capocci, L., Sanctis, C. D., Comerci, L., Pompeo, F., et al. (2017) · Scientific Reports · doi:10.1038/srep41316 · Cited by 105
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
Pla, P., Orvoën, S., Saudou, F., David, D. J. P., & Humbert, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00135 · Cited by 97
Callaghan, B. L., Fields, A., Gee, D. G., Gabard-Durnam, L., Caldera, C., Humphreys, K. L., Goff, B., Flannery, J., Telzer, E. H., Shapiro, M., et al. (2020) · Development and Psychopathology · doi:10.1017/s0954579419000087 · Cited by 93
Body weight is a robust predictor of clinical progression in Huntington disease
van der Burg, J. M. M., Gardiner, S. L., Ludolph, A. C., Landwehrmeyer, G. B., Roos, R. A. C., & Aziz, N. A. (2017) · Annals of Neurology · doi:10.1002/ana.25007 · Cited by 89
Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms
Giralt, A., Saavedra, A., Alberch, J., & Pérez‐Navarro, E. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-120023 · Cited by 78
Upper gastrointestinal findings in Huntington’s disease: patients suffer but do not complain
Andrich, J., Wobben, M., Klotz, P., Goetze, O., & Carsten Saft, C. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0310-1 · Cited by 63
Soylu-Kucharz, R., Sandelius, Å., Sjögren, M., Blennow, K., Wild, E. J., Zetterberg, H., & Björkqvist, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-14179-1 · Cited by 63
Self-citationStructure and Regulation of Intestinal Epithelial Tight Junctions
Ivanov, A. I. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4711-5_6 · Cited by 59
Systemic energy homeostasis in Huntington's disease patients
Aziz, N. A., Pijl, H., Frölich, M., Snel, M., Streefland, T. C. M., Roelfsema, F., & Roos, R. A. C. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.191833 · Cited by 58
Analysis of Intestinal Permeability in Mice
Gupta, J., & Nebreda, Á. R. (2014) · BIO-PROTOCOL · doi:10.21769/bioprotoc.1289 · Cited by 52
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease
Sjögren, M., Duarte, A. I., McCourt, A. C., Shcherbina, L., Wierup, N., & Björkqvist, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13713-5 · Cited by 21
Self-citationBladder dysfunction in presymptomatic gene carriers and patients with Huntington’s disease
Kolenc, M., Moharić, M., Kobal, J., & Podnar, S. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7494-5 · Cited by 17
Anorectal Dysfunction in Presymptomatic Mutation Carriers and Patients with Huntington’s Disease
Kobal, J., Kolenc, M., Koželj, M., & Podnar, S. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-170280 · Cited by 16
The gut microbiome in psychopharmacology and psychiatry
Cryan, J. F., & de Wit, H. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05288-y · Cited by 8
Cited by
Sorted by citations
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Aburto, M. R., & Cryan, J. F. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00890-0 · Cited by 407
Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204
Current and Possible Future Therapeutic Options for Huntington’s Disease
Ferguson, M. W., Kennedy, C. J., Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221092517 · Cited by 133
Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer’s Disease
Shukla, P. K., Delotterie, D. F., Xiao, J., Pierre, J. F., Rao, R., McDonald, M. P., & Khan, M. M. (2021) · Cells · doi:10.3390/cells10040779 · Cited by 105
Metadata
- Authors
- Stan, T. L., Soylu-Kucharz, R., Burleigh, S., Prykhodko, O., Cao, L., Franke, N., Sjögren, M., Haikal, C., Hållenius, F., & Björkqvist, M.
- Affiliations
- Lund University (SE)
- Corresponding author
- Soylu-Kucharz, Rana
- ORCID
- Venue
- Scientific Reports
- Published
- 2020-10-26
- Volume
- 10
- Issue
- 1
- Pages
- 18270-18270
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC7589489
- OpenAlex
- W3094034464
- Cited by
- 101
- References
- 48
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 22 · 2023: 17 · 2022: 26 · 2021: 11
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Royal Physiographic Society of Lund
- Per Westlings funds
- Knut och Alice Wallenbergs Stiftelse
- Svenska Sällskapet för Medicinsk Forskning
- The Direktör Albert Påhlsson Foundation, Sweden
- Vetenskapsrådet (#2017-01080)
- Lund University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- Huntington's disease, intestinal permeability, gut dysbiosis, R6/2 mouse model, tight junction proteins, occludin, zonula occludens, gut microbiota, Bacteroidetes, Firmicutes, leaky gut, weight loss, colon length
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bacteria, Body Weight, Disease Models, Animal, DNA, Bacterial, DNA, Ribosomal, Female, Humans, Huntington Disease, Male, Phylogeny, RNA, Ribosomal, 16S, Sequence Analysis, DNA, Bacterial Physiological Phenomena, Bacterial Translocation, Mice, Tight Junction Proteins, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review